News
Zacks Investment Research on MSN1h
Incyte Gets FDA Approval for Zynyz in New Cancer IndicationIncyte INCY announced that the FDA has approved its new drug, Zynyz (retifanlimab-dlwr), a PD-1 inhibitor, for treating a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback